Russell Investments Group’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.23M | Sell |
87,885
-110,373
| -56% | -$1.54M | ﹤0.01% | 1962 |
|
|
2025
Q1 | $2.67M | Sell |
198,258
-181,338
| -48% | -$2.44M | ﹤0.01% | 1534 |
|
|
2024
Q4 | $7.28M | Sell |
379,596
-62,738
| -14% | -$1.2M | 0.01% | 973 |
|
|
2024
Q3 | $10.1M | Buy |
442,334
+92,703
| +27% | +$2.11M | 0.01% | 835 |
|
|
2024
Q2 | $4.55M | Buy |
349,631
+28,025
| +9% | +$365K | 0.01% | 1195 |
|
|
2024
Q1 | $5.63M | Sell |
321,606
-7,878
| -2% | -$138K | 0.01% | 1113 |
|
|
2023
Q4 | $7.18M | Buy |
329,484
+30,343
| +10% | +$661K | 0.01% | 960 |
|
|
2023
Q3 | $4.59M | Buy |
299,141
+195,616
| +189% | +$3M | 0.01% | 1124 |
|
|
2023
Q2 | $2.46M | Buy |
103,525
+18,790
| +22% | +$447K | ﹤0.01% | 1452 |
|
|
2023
Q1 | $2.16M | Sell |
84,735
-392
| -0.5% | -$9.97K | ﹤0.01% | 1538 |
|
|
2022
Q4 | $2.49M | Buy |
85,127
+40,328
| +90% | +$1.18M | 0.01% | 1455 |
|
|
2022
Q3 | $917K | Buy |
+44,799
| New | +$917K | ﹤0.01% | 1976 |
|
|
2017
Q4 | – | Sell |
-1,072
| Closed | -$147K | – | 3013 |
|
|
2017
Q3 | $147K | Buy |
+1,072
| New | +$147K | ﹤0.01% | 2720 |
|